Empreses emergents
2018
AORTYX SLLa solució definitiva per a malalties aòrtiques Pegat endovascular adhesiu que afavoreix la regeneració dels teixits i la trombosi de la falsa llum.
Dades financeres
Propietat CERCA
Altres accionistes públics catalans
Logotip
Àrees d'estat i deeptech
Estat de l'empresa i àrees de tecnologia profunda de l'empresaEstat de l'empresa
Àrea DeepTech
Informació sobre la spin-off
Descripció de l'empresa
Aortyx is a pioneer company that aims at providing a new generation of endovascular devices to treat vascular diseases.
Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
At Aortyx, we aim at delivering the ultimate solution for aortic diseases, tackling clear unmet needs, generating positive impact in our society with the most advanced available technology.
Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cell migration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
At Aortyx, we aim at delivering the ultimate solution for aortic diseases, tackling clear unmet needs, generating positive impact in our society with the most advanced available technology.
Descripció del producte
Bioresorbable - Our material has been designed to dissolve progressively two years after its implantation. No toxic nor inflammatory responses are expected.
Viscoelastic - The microstructure of our device is specially designed to mimic the mechanical properties of the aorta. Our patch has the ability to expand and contract with every cardiac cycle.
Thrombogenic - Controlled clotting of the false lumen allows a better restoration of flow through the true lumen and to avoid peripheral malperfusion.
Regenerative - The extracellular matrix molecules that decorate the patch promote re-endothelialization of the affected dissected part.
Drug delivery platform - Our device could be used as a local drug delivery platform thanks to the specially designed microstructure and the material used to create it.
Viscoelastic - The microstructure of our device is specially designed to mimic the mechanical properties of the aorta. Our patch has the ability to expand and contract with every cardiac cycle.
Thrombogenic - Controlled clotting of the false lumen allows a better restoration of flow through the true lumen and to avoid peripheral malperfusion.
Regenerative - The extracellular matrix molecules that decorate the patch promote re-endothelialization of the affected dissected part.
Drug delivery platform - Our device could be used as a local drug delivery platform thanks to the specially designed microstructure and the material used to create it.